Surrogate markers of intestinal dysfunction associated with survival in advanced cancers
Deviations in the diversity and composition of the gut microbiota are called “gut dysbiosis”. They have been linked to various chronic diseases including cancers and resistance to immunotherapy. Stool shotgun based-metagenomics informs on the ecological composition of the gut microbiota and the prev...
Saved in:
| Main Authors: | Roxanne Birebent, Damien Drubay, Carolina Alves Costa Silva, Federica Marmorino, Giacomo Vitali, Gianmarco Piccinno, Yoan Hurtado, Adele Bonato, Lorenzo Belluomini, Meriem Messaoudene, Bertrand Routy, Marine Fidelle, Gerard Zalcman, Julien Mazieres, Clarisse Audigier-Valette, Denis Moro-Sibilot, François Goldwasser, Arnaud Scherpereel, Hervé Pegliasco, François Ghiringhelli, Anna Reni, Fabrice Barlesi, Laurence Albiges, David Planchard, Stéphanie Martinez, Benjamin Besse, Nicola Segata, Chiara Cremolini, Laurence Zitvogel, Valerio Iebba, Lisa Derosa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | OncoImmunology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2484880 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preliminary Study of <i>CCR9</i> and <i>MAdCAM-1</i> Upregulation and Immune Imbalance in Canine Chronic Enteropathy: Findings Based on Histopathological Analysis
by: Macarena Pino, et al.
Published: (2025-06-01) -
Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
by: Marine Fidelle, et al.
Published: (2023-12-01) -
Benzodiazepines compromise the outcome of cancer immunotherapy
by: Léa Montégut, et al.
Published: (2024-12-01) -
Du concept de situation dans les didactiques de l’histoire, de la géographie et de l’éducation à la citoyenneté
by: François Audigier
Published: (2011-11-01) -
Benzodiazepines interfere with the efficacy of pembrolizumab-based cancer immunotherapy. Results of a nationwide cohort study including over 50,000 participants with advanced lung cancer
by: Léa Montégut, et al.
Published: (2025-12-01)